1988
DOI: 10.1002/ijc.2910410126
|View full text |Cite
|
Sign up to set email alerts
|

Adhesion characteristics of human melanoma cell lines of varying metastatic potential

Abstract: The adhesive behaviour of a series of human melanoma cell lines, of varying metastatic potential, to basement membrane and stromal components was investigated in vitro. Experimental metastatic propensity was assessed from the number of pulmonary nodules formed after i.v. injection of cells into BALB/c nude mice. All cell lines showed similar kinetics of attachment when tested on plastic, type-I collagen films, type-I collagen hydrated gels, fibronectin, laminin type-IV collagen substrates and bovine aortic end… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

1
5
1

Year Published

1989
1989
2003
2003

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 15 publications
(7 citation statements)
references
References 15 publications
1
5
1
Order By: Relevance
“…The percentages of tumor cells bound to endothelial cell monolayers and to ECM were similar to those obtained by Vlodavsky et al [23]. Comparison between the two variants showed that a lower percentage of the HM than of the LM cells were able to attach to ABAE cells as well as to ECM: TAU-39 cells attached 160 Klci n/Sav ion/Staroselsky/Leibov ici Metastatic Capacity and Adhesion to Endothelial Cells and ECM [35][36][37], other groups found no differences in adherence capacity between variants of malignancy [38] and others have found results similar to ours, namely a preferential adherence ability to endothelial monolayers and ECM of LM than of HM tumor cells [39], A possible interpretation of the higher attachment of LM compared to HM cells to endothelial cells and their ECM could be that tumor cells should be able not only to attach to these host barriers but also to detach from them, in order to be able to continue their spread to the target organs. It is possible indeed that the capacity of the tumor cells to detach from the blood vessel barrier facilitates the extravasation step and the two lymphoma variants differ at this particular stage.…”
Section: Discussionsupporting
confidence: 71%
“…The percentages of tumor cells bound to endothelial cell monolayers and to ECM were similar to those obtained by Vlodavsky et al [23]. Comparison between the two variants showed that a lower percentage of the HM than of the LM cells were able to attach to ABAE cells as well as to ECM: TAU-39 cells attached 160 Klci n/Sav ion/Staroselsky/Leibov ici Metastatic Capacity and Adhesion to Endothelial Cells and ECM [35][36][37], other groups found no differences in adherence capacity between variants of malignancy [38] and others have found results similar to ours, namely a preferential adherence ability to endothelial monolayers and ECM of LM than of HM tumor cells [39], A possible interpretation of the higher attachment of LM compared to HM cells to endothelial cells and their ECM could be that tumor cells should be able not only to attach to these host barriers but also to detach from them, in order to be able to continue their spread to the target organs. It is possible indeed that the capacity of the tumor cells to detach from the blood vessel barrier facilitates the extravasation step and the two lymphoma variants differ at this particular stage.…”
Section: Discussionsupporting
confidence: 71%
“…These results are inconsistent with most, but not all [36,37] previous studies, showing that highly metastatic cells possessed greater preferential adhesion affinities to purified FN, LN, or CL-IV substrates [13,[38][39][40][41] or vascular endothelial cell ECM [42,43] than weakly metastatic cells.…”
Section: Discussioncontrasting
confidence: 56%
“…G antigen 7 is expressed in prostate cancer (43), and G antigen 7c was proposed to be an antiapoptotic gene (57). Similarly, MAGE expression is associated with metastasis (53,54). SSX2 was shown to be expressed in a wide variety of tumors (50) and was identified as one of 13 antigens that react exclusively with sera from colon cancer patients but not with sera from normal patients (58).…”
Section: Discussionmentioning
confidence: 99%